G Mahé1,2,3,4,5, P Abraham1,2, A Humeau-Heurtier6, L Gascoin2, G Lefthériotis1,2, S Durand7. 1. Biologie Neurovasculaire et Mitochondriale Intégrée (BNMI) - Unité mixte UMR CNRS 6214 / INSERM U 1083, Faculté de Médecine, Angers, France. 2. Laboratory of Vascular Investigations, University Hospital of Angers, France. 3. CHU Rennes, Imagerie cœur-vaisseaux, F-35033, Rennes, France. 4. INSERM, Clinical Investigation Center CIC 1414, F-34043, Rennes, France. 5. Université de Rennes 1, F-34043, Rennes, France. 6. LARIS - Laboratoire Angevin de Recherche en Ingénierie des Systèmes, Université d'Angers, 62 avenue Notre-Dame du Lac, 49000, Angers, France. 7. Université du Maine, EA 4334, Motricité, Interactions, Performance, LUNAM Université, Le Mans, 72085, Cedex 9, France.
Abstract
AIMS: Current-induced vasodilation (CIV) is an axon-reflex response observed during monopolar current application such as iontophoresis. Cyclo-oxygenase derivates (COD) participate in CIV and act as sensitizing agents at the anodal level. Mechanisms involved during cathodal current application (CCA) are partially unknown. In a randomized double-blind crossover trial, we tested in 16 healthy subjects (i) the influence of the inter-stimulation interval (I-I) by comparing CIV following all-at-once 10 s CCA against 2 × 5 s CCA with intervals ranging from15 s-16 min and (ii) the participation of COD in CIV using 1 g aspirin or placebo intake. METHODS: Measurements were repeated 2 h and 14 days after treatment. Laser Doppler flowmetry assessed cutaneous blood flow, reported in multiples of baseline. RESULTS: Before treatment, peak vasodilation 10 min after the last current application (CVCstim2 ) increased compared with baseline whatever the I-I. Increase in CVCstim2 from baseline was greater for the 4 min (9.4 (5.3, 10.9) times; median (1(st) percentile, 3(rd) percentile)) and higher I-Is compared with all-at-once delivery (3.0 (2.1, 4.3) times, P < 0.05). The response was similar after placebo but aspirin abolished this vasodilation (increase by 1.2 (1.1, 1.3) times for all-at-once delivery and by 1.5 (1.3, 1.7) ± 0.3 times for 4 min interval, 2 h after aspirin intake) that recovered after 14 days. CONCLUSIONS: This confirms the participation of COD in CIV with CCA and their sensitizing action. This model can represent an attractive way to study the axon-reflex and sensitizing function of COD in humans.
RCT Entities:
AIMS: Current-induced vasodilation (CIV) is an axon-reflex response observed during monopolar current application such as iontophoresis. Cyclo-oxygenase derivates (COD) participate in CIV and act as sensitizing agents at the anodal level. Mechanisms involved during cathodal current application (CCA) are partially unknown. In a randomized double-blind crossover trial, we tested in 16 healthy subjects (i) the influence of the inter-stimulation interval (I-I) by comparing CIV following all-at-once 10 s CCA against 2 × 5 s CCA with intervals ranging from15 s-16 min and (ii) the participation of COD in CIV using 1 g aspirin or placebo intake. METHODS: Measurements were repeated 2 h and 14 days after treatment. Laser Doppler flowmetry assessed cutaneous blood flow, reported in multiples of baseline. RESULTS: Before treatment, peak vasodilation 10 min after the last current application (CVCstim2 ) increased compared with baseline whatever the I-I. Increase in CVCstim2 from baseline was greater for the 4 min (9.4 (5.3, 10.9) times; median (1(st) percentile, 3(rd) percentile)) and higher I-Is compared with all-at-once delivery (3.0 (2.1, 4.3) times, P < 0.05). The response was similar after placebo but aspirin abolished this vasodilation (increase by 1.2 (1.1, 1.3) times for all-at-once delivery and by 1.5 (1.3, 1.7) ± 0.3 times for 4 min interval, 2 h after aspirin intake) that recovered after 14 days. CONCLUSIONS: This confirms the participation of COD in CIV with CCA and their sensitizing action. This model can represent an attractive way to study the axon-reflex and sensitizing function of COD in humans.
Authors: T Minami; E Okuda-Ashitaka; Y Hori; S Sakuma; T Sugimoto; K Sakimura; M Mishina; S Ito Journal: Eur J Neurosci Date: 1999-06 Impact factor: 3.386
Authors: William R Ferrell; Jane E Ramsay; Naomi Brooks; John C Lockhart; Sylvia Dickson; Grainne M McNeece; Ian A Greer; Naveed Sattar Journal: J Vasc Res Date: 2002 Sep-Oct Impact factor: 1.934
Authors: M Grossmann; M J Jamieson; D L Kellogg; W A Kosiba; P E Pergola; C G Crandall; A M Shepherd Journal: Microvasc Res Date: 1995-11 Impact factor: 3.514
Authors: P Marche; S Dubois; P Abraham; E Parot-Schinkel; L Gascoin; A Humeau-Heurtier; P H Ducluzeau; G Mahe Journal: Sci Rep Date: 2017-03-13 Impact factor: 4.379